Codexis (CDXS) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Codexis | 251.43 Mn | 186.29 Mn | 13.18 Mn | -1,412.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,412.18% |
| Dec 31, 2025 | 242.78% |
| Sep 30, 2025 | -107.57% |
| Jun 30, 2025 | 121.39% |
| Mar 31, 2025 | 86.65% |
| Dec 31, 2024 | -83.22% |
| Sep 30, 2024 | 207.63% |
| Jun 30, 2024 | -267.51% |
| Mar 31, 2024 | 36.55% |
| Dec 31, 2023 | -287.80% |
| Sep 30, 2023 | -194.39% |
| Jun 30, 2023 | -157.56% |
| Mar 31, 2023 | 50.58% |
| Dec 31, 2022 | 320.93% |
| Sep 30, 2022 | 279.81% |
| Jun 30, 2022 | 59.34% |
| Mar 31, 2022 | -151.76% |
| Dec 31, 2021 | -103.08% |
| Sep 30, 2021 | -150.57% |
| Jun 30, 2021 | 12.28% |
| Mar 31, 2021 | -179.44% |
| Dec 31, 2020 | 4,794.86% |
| Sep 30, 2020 | -217.82% |
| Jun 30, 2020 | -125.37% |
| Mar 31, 2020 | 40.41% |
| Dec 31, 2019 | -42.25% |
| Sep 30, 2019 | -328.98% |
| Jun 30, 2019 | 57.37% |
| Mar 31, 2019 | 22.79% |
| Dec 31, 2018 | -115.67% |
| Sep 30, 2018 | 111.25% |
| Jun 30, 2018 | 96.73% |
| Mar 31, 2018 | -30.21% |
| Dec 31, 2017 | 43.71% |
| Sep 30, 2017 | 32.32% |
| Jun 30, 2017 | 7,771.96% |
| Mar 31, 2017 | -381.89% |
| Dec 31, 2016 | -18.24% |
| Sep 30, 2016 | -2,136.71% |
| Jun 30, 2016 | 103.40% |
| Mar 31, 2016 | 74.35% |
| Dec 31, 2015 | 27.09% |
| Sep 30, 2015 | -74.51% |
| Jun 30, 2015 | -80.96% |
| Mar 31, 2015 | -518.97% |
| Dec 31, 2014 | 203.85% |
| Sep 30, 2014 | 126.13% |
| Jun 30, 2014 | -364.69% |
| Mar 31, 2014 | 233.81% |
| Dec 31, 2013 | -174.34% |
| Sep 30, 2013 | -161.74% |
| Jun 30, 2013 | 111.71% |
| Mar 31, 2013 | -213.86% |
| Dec 31, 2012 | 247.84% |
| Sep 30, 2012 | 537.12% |
| Jun 30, 2012 | 52.96% |
| Mar 31, 2012 | 103.52% |
| Dec 31, 2011 | 83.78% |
| Sep 30, 2011 | -104.25% |